SLUG: Critical regulator of epithelial cell identity in breast development and cancer http://www.tandfonline.com/doi/pdf/10.4161/19336918.2014.972740

Cell Adhesion and Migration

Volumn 8, Issue 6, 2014, Pages 578-587

  Phillips, Sarah ^a,b   Kuperwasser, Charlotte ^a,b  

^a TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b TUFTS MEDICAL CENTER   (United States)

Author keywords

Breast cancer; Cellular plasticity; Differentiation; EMT; Mammary stem cells; SLUG

Indexed keywords

TRANSCRIPTION FACTOR SLUG; SNAIL FAMILY TRANSCRIPTION FACTORS; TRANSCRIPTION FACTOR;

BRANCHING MORPHOGENESIS; BREAST CANCER; BREAST CARCINOGENESIS; BREAST DEVELOPMENT; BREAST EPITHELIUM; BREAST EPITHELIUM CELL; CANCER GROWTH; CANCER STEM CELL; CELL DIFFERENTIATION; CELL FATE; CELL LINEAGE; CELL POPULATION; EPITHELIAL MESENCHYMAL TRANSITION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; MALIGNANT TRANSFORMATION; MAMMARY GLAND; NONHUMAN; PHENOTYPE; PLASTICITY; PROMOTER REGION; PROTEIN EXPRESSION; REVIEW; TRANSCRIPTION REGULATION; ANIMAL; BREAST; BREAST NEOPLASMS; CYTOLOGY; DISEASE COURSE; EMBRYOLOGY; EPITHELIUM CELL; FEMALE; GENETICS; GROWTH, DEVELOPMENT AND AGING; METABOLISM; PATHOPHYSIOLOGY; PHYSIOLOGY; TUMOR CELL LINE;

ANIMALS; BREAST; BREAST NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL LINEAGE; DISEASE PROGRESSION; EPITHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; HUMANS; TRANSCRIPTION FACTORS;

EID: 84921763794     PISSN: 19336918     EISSN: 19336926     Source Type: Journal    
DOI: 10.4161/19336918.2014.972740     Document Type: Review

References (114)

1. Hemavathy K, Ashraf SI, Ip YT. Snail/slug family of repressors: Slowly going into the fast lane of development and cancer. Gene 2000; 257: 1-12; PMID: 11054563; http://dx.doi.org/S0378-1119(00) 00371-1 [pii]
2. Nieto MA. The snail superfamily of zinc-finger transcription factors. Nat Rev Mol Cell Biol 2002; 3: 155-66; PMID: 11994736; http://dx.doi.org/10.1038/nrm757
3. Hemavathy K, Guru SC, Harris J, Chen JD, Ip YT. Human slug is a repressor that localizes to sites of active transcription. Mol Cell Biol 2000; 20: 5087-95; PMID: 10866665
4. Isaac A, Sargent MG, Cooke J. Control of vertebrate left-right asymmetry by a snail-related zinc finger gene. Science 1997; 275: 1301-4; PMID: 9036854
5. Inukai T, Inoue A, Kurosawa H, Goi K, Shinjyo T, Ozawa K, Mao M, Inaba T, Look AT. SLUG, a ces-1-related zinc finger transcription factor gene with antiapoptotic activity, is a downstream target of the E2A-HLF oncoprotein. Mol Cell 1999; 4: 343-52; PMID: 10518215
6. Vega S, Morales AV, Ocana OH, Valdes F, Fabregat I, Nieto MA. Snail blocks the cell cycle and confers resistance to cell death. Genes Dev 2004; 18: 1131-43; PMID: 15155580; http://dx.doi.org/10.1101/gad.294104
7. Boutet A, De Frutos CA, Maxwell PH, Mayol MJ, Romero J, Nieto MA. Snail activation disrupts tissue homeostasis and induces fibrosis in the adult kidney. EMBO J 2006; 25: 5603-13; PMID: 17093497; http://dx.doi.org/7601421 [pii]
8. Martinez-Alvarez C, Blanco MJ, Perez R, Rabadan MA, Aparicio M, Resel E, Martinez T, Nieto MA. Snail family members and cell survival in physiological and pathological cleft palates. Dev Biol 2004; 265: 207-18; PMID: 14697364; http://dx.doi.org/S0012160603005748 [pii]
9. Kajita M, McClinic KN, Wade PA. Aberrant expression of the transcription factors snail and slug alters the response to genotoxic stress. Mol Cell Biol 2004; 24: 7559-66; PMID: 15314165; http://dx.doi.org/10.1128/MCB.24.17.7559-7566.2004
10. Barrallo-Gimeno A, Nieto MA. The snail genes as inducers of cell movement and survival: Implications in development and cancer. Development 2005; 132: 3151-61; PMID: 15983400; http://dx.doi.org/132/14/3151 [pii]
11. Dhasarathy A, Phadke D, Mav D, Shah RR, Wade PA. The transcription factors snail and slug activate the transforming growth factor-beta signaling pathway in breast cancer. PLoS One 2011; 6: e26514; PMID: 22028892; http://dx.doi.org/10.1371/journal.pone.0026514
12. Kurrey NKKA, Bapat SA. Snail and slug are major determinants of ovarian cancer invasiveness at the transcription level. Gynecol Oncol 2005; 97: 155-65; PMID: 15790452; http://dx.doi.org/S0090-8258(04) 01058-3 [pii]
13. Uygur B, Wu WS. SLUG promotes prostate cancer cell migration and invasion via CXCR4/CXCL12 axis. Mol Cancer 2011; 10: 139, 4598-10-139; PMID: 22074556; http://dx.doi.org/10.1186/1476-4598-10-139 [doi]
14. Turner FE, Broad S, Khanim FL, Jeanes A, Talma S, Hughes S, Tselepis C, Hotchin NA. Slug regulates integrin expression and cell proliferation in human epidermal keratinocytes. J Biol Chem 2006; 281: 21321-31; PMID: 16707493; http://dx.doi.org/M509731200 [pii]
15. Emadi Baygi M, Soheili ZS, Essmann F, Deezagi A, Engers R, Goering W, Schulz WA. Slug/SNAI2 regulates cell proliferation and invasiveness of metastatic prostate cancer cell lines. Tumour Biol 2010; 31: 297-307; PMID: 20506051; http://dx.doi.org/10.1007/s13277-010-0037-5
16. Cobaleda C, Perez-Caro M, Vicente-Duenas C, Sanchez-Garcia I. Function of the zinc-finger transcription factor SNAI2 in cancer and development. Annu Rev Genet 2007; 41: 41-61; PMID: 17550342; http://dx.doi.org/10.1146/annurev.genet.41.110306.130146
17. Shirley SH, Hudson LG, He J, Kusewitt DF. The skinny on slug. Mol Carcinog 2010; 49: 851-61; PMID: 20721976; http://dx.doi.org/10.1002/mc.20674.
18. Grimes HL, Chan TO, Zweidler-McKay PA, Tong B, Tsichlis PN. The gfi-1 proto-oncoprotein contains a novel transcriptional repressor domain, SNAG, and inhibits G1 arrest induced by interleukin-2 withdrawal. Mol Cell Biol 1996; 16: 6263-72; PMID: 8887656
19. Chiang C, Ayyanathan K. Snail/gfi-1 (SNAG) family zinc finger proteins in transcription regulation, chromatin dynamics, cell signaling, development, and disease. Cytokine Growth Factor Rev 2013; 24: 123-31; PMID: 23102646; http://dx.doi.org/10.1016/j.cytogfr.2012.09.002.
20. Sefton M, Sanchez S, Nieto MA. Conserved and divergent roles for members of the snail family of transcription factors in the chick and mouse embryo. Development 1998; 125: 3111-21; PMID: 9671584
21. Molina-Ortiz P, Villarejo A, MacPherson M, Santos V, Montes A, Souchelnytskyi S, Portillo F, Cano A. Characterization of the SNAG and SLUG domains of Snail2 in the repression of E-cadherin and EMT induction: Modulation by serine 4 phosphorylation. PLoS One 2012; 7: e36132; PMID: 22567133; http://dx.doi.org/10.1371/journal.pone.0036132.
22. Jiang R, Lan Y, Norton CR, Sundberg JP, Gridley T. The slug gene is not essential for mesoderm or neural crest development in mice. Dev Biol 1998; 198: 277-85; PMID: 9659933
23. Carver EA, Jiang R, Lan Y, Oram KF, Gridley T. The mouse snail gene encodes a key regulator of the epithelial-mesenchymal transition. Mol Cell Biol 2001; 21: 8184-8; PMID: 11689706; http://dx.doi.org/10.1128/MCB.21.23.8184-8188.2001 [doi]
24. Moreno-Bueno G, Cubillo E, Sarrio D, Peinado H, Rodriguez-Pinilla SM, Villa S, Bolos V, Jorda M, Fabra A, Portillo F, et al. Genetic profiling of epithelial cells expressing E-cadherin repressors reveals a distinct role for snail, slug, and E47 factors in epithelialmesenchymal transition. Cancer Res 2006; 66: 9543-56; PMID: 17018611; http://dx.doi.org/10.1158/0008-5472.CAN-06-0479
25. Bolos V, Peinado H, Perez-Moreno MA, Fraga MF, Esteller M, Cano A. The transcription factor slug represses E-cadherin expression and induces epithelial to mesenchymal transitions: A comparison with snail and E47 repressors. J Cell Sci 2003; 116: 499-511; PMID: 12508111
26. Gras B, Jacqueroud L, Wierinckx A, Lamblot C, Fauvet F, Lachuer J, Puisieux A, Ansieau S. Snail family members unequally trigger EMT and thereby differ in their ability to promote the neoplastic transformation of mammary epithelial cells. PLoS One 2014; 9: e92254; PMID: 24638100; http://dx.doi.org/10.1371/journal.pone.0092254 [doi]
27. Villarejo A, Cortes-Cabrera A, Molina-Ortiz P, Portillo F, Cano A. Differential role of Snail1 and Snail2 zinc fingers in E-cadherin repression and epithelial to mesenchymal transition. J Biol Chem 2014; 289: 930-41; PMID: 24297167; http://dx.doi.org/10.1074/jbc.M113.528026
28. Come C, Magnino F, Bibeau F, De Santa Barbara P, Becker KF, Theillet C, Savagner P. Snail and slug play distinct roles during breast carcinoma progression. Clin Cancer Res 2006; 12: 5395-402; PMID: 17000672; http://dx.doi.org/10.1158/1078-0432.CCR-06-0478
29. Visvader JE. Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis. Genes Dev 2009; 23: 2563-77; PMID: 19933147; http://dx.doi.org/10.1101/gad.1849509
30. Smalley MJ, Titley J, Paterson H, Perusinghe N, Clarke C, O'Hare MJ. Differentiation of separated mouse mammary luminal epithelial and myoepithelial cells cultured on EHS matrix analyzed by indirect immunofluorescence of cytoskeletal antigens. J Histochem Cytochem 1999; 47: 1513-24; PMID: 10567435
31. Warburton MJ, Mitchell D, Ormerod EJ, Rudland P. Distribution of myoepithelial cells and basement membrane proteins in the resting, pregnant, lactating, and involuting rat mammary gland. J Histochem Cytochem 1982; 30: 667-76; PMID: 6179984
32. Dairkee S, Heid HW. Cytokeratin profile of immunomagnetically separated epithelial subsets of the human mammary gland. In Vitro Cell Dev Biol Anim 1993; 29A: 427-32; PMID: 7686143
33. Gudjonsson T, Adriance MC, Sternlicht MD, Petersen OW, Bissell MJ. Myoepithelial cells: Their origin and function in breast morphogenesis and neoplasia. J Mammary Gland Biol Neoplasia 2005; 10: 261-72; PMID: 16807805; http://dx.doi.org/10.1007/s10911-005-9586-4
34. Sopel M. The myoepithelial cell: Its role in normal mammary glands and breast cancer. Folia Morphol (Warsz) 2010; 69: 1-14; PMID: 20235044
35. Jeselsohn R, Brown NE, Arendt L, Klebba I, Hu MG, Kuperwasser C, Hinds PW. Cyclin D1 kinase activity is required for the self-renewal of mammary stem and progenitor cells that are targets of MMTV-ErbB2 tumorigenesis. Cancer Cell 2010; 17: 65-76; PMID: 20129248; http://dx.doi.org/10.1016/j.ccr.2009.11.024
36. Shehata M, Teschendorff A, Sharp G, Novcic N, Russell A, Avril S, Prater M, Eirew P, Caldas C, Watson CJ, et al. Phenotypic and functional characterization of the luminal cell hierarchy of the mammary gland. Breast Cancer Res 2012; 14: R134; PMID: 23088371; http://dx.doi.org/10.1186/bcr/3334
37. Kittrell FS, Carletti MZ, Kerbawy S, Heestand J, Xian W, Zhang M, Lamarca HL, Sonnenberg A, Rosen JM, Medina D, et al. Prospective isolation and characterization of committed and multipotent progenitors from immortalized mouse mammary epithelial cells with morphogenic potential. Breast Cancer Res 2011; 13: R41; PMID: 21466693; http://dx.doi.org/10.1186/bcr2863
38. Van Keymeulen A, Rocha AS, Ousset M, Beck B, Bouvencourt G, Rock J, Sharma N, Dekoninck S, Blanpain C. Distinct stem cells contribute to mammary gland development and maintenance. Nature 2011; 479: 189-93; PMID: 21983963; http://dx.doi.org/10.1038/nature10573
39. dos Santos CO, Rebbeck C, Rozhkova E, Valentine A, Samuels A, Kadiri LR, Osten P, Harris EY, Uren PJ, Smith AD, et al. Molecular hierarchy of mammary differentiation yields refined markers of mammary stem cells. Proc Natl Acad Sci U S A 2013; 110: 7123-30; PMID: 23580620; http://dx.doi.org/10.1073/pnas.1303919110
40. Asselin-Labat ML, Sutherland KD, Barker H, Thomas R, Shackleton M, Forrest NC, Hartley L, Robb L, Grosveld FG, van der Wees J, et al. Gata-3 is an essential regulator of mammary-gland morphogenesis and luminal-cell differentiation. Nat Cell Biol 2007; 9: 201-9; PMID: 17187062; http://dx.doi.org/10.1038/ncb1530
41. Eirew P, Stingl J, Raouf A, Turashvili G, Aparicio S, Emerman JT, Eaves CJ. A method for quantifying normal human mammary epithelial stem cells with in vivo regenerative ability. Nat Med 2008; 14: 1384-9; PMID: 19029987; http://dx.doi.org/10.1038/nm.1791
42. Lim E, Vaillant F, Wu D, Forrest NC, Pal B, Hart AH, Asselin-Labat ML, Gyorki DE, Ward T, Partanen A, et al. Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers. Nat Med 2009; 15: 907-13; PMID: 19648928; http://dx.doi.org/10.1038/nm.2000
43. Keller PJ, Lin AF, Arendt LM, Klebba I, Jones AD, Rudnick JA, DiMeo TA, Gilmore H, Jefferson DM, Graham RA, et al. Mapping the cellular and molecular heterogeneity of normal and malignant breast tissues and cultured cell lines. Breast Cancer Res 2010; 12: R87; PMID: 20964822; http://dx.doi.org/10.1186/bcr2755
44. Raouf A, Zhao Y, To K, Stingl J, Delaney A, Barbara M, Iscove N, Jones S, McKinney S, Emerman J, et al. Transcriptome analysis of the normal human mammary cell commitment and differentiation process. Cell Stem Cell 2008; 3: 109-18; PMID: 18593563; http://dx.doi.org/10.1016/j.stem.2008.05.018
45. Regan JL, Kendrick H, Magnay FA, Vafaizadeh V, Groner B, Smalley MJ. C-kit is required for growth and survival of the cells of origin of Brca1-mutationassociated breast cancer. Oncogene 2012; 31: 869-83; PMID: 21765473; http://dx.doi.org/10.1038/onc.2011.289
46. Shackleton M, Vaillant F, Simpson KJ, Stingl J, Smyth GK, Asselin-Labat ML, Wu L, Lindeman GJ, Visvader JE. Generation of a functional mammary gland from a single stem cell. Nature 2006; 439: 84-8; PMID: 16397499; http://dx.doi.org/10.1038/nature04372
47. Stingl J, Eaves CJ, Zandieh I, Emerman JT. Characterization of bipotent mammary epithelial progenitor cells in normal adult human breast tissue. Breast Cancer Res Treat 2001; 67: 93-109; PMID: 11519870
48. Rios AC, Fu NY, Lindeman GJ, Visvader JE. In situ identification of bipotent stem cells in the mammary gland. Nature 2014; 506: 322-7; PMID: 24463516; http://dx.doi.org/10.1038/nature12948
49. Proia TA, Keller PJ, Gupta PB, Klebba I, Jones AD, Sedic M, Gilmore H, Tung N, Naber SP, Schnitt S, et al. Genetic predisposition directs breast cancer phenotype by dictating progenitor cell fate. Cell Stem Cell 2011; 8: 149-63; PMID: 21295272; http://dx.doi.org/10.1016/j.stem.2010.12.007
50. Phillips S, Prat A, Sedic M, Proia T, Wronski A, Mazumdar S, Skibinski A, Shirley SH, Perou CM, Gill G, et al. Cell-state transitions regulated by SLUG are critical for tissue regeneration and tumor initiation. Stem Cell Reports 2014; In Press
51. Guo W, Keckesova Z, Donaher JL, Shibue T, Tischler V, Reinhardt F, Itzkovitz S, Noske A, Zurrer-Hardi U, Bell G, et al. Slug and Sox9 cooperatively determine the mammary stem cell state. Cell 2012; 148: 1015-28; PMID: 22385965; http://dx.doi.org/10.1016/j.cell.2012.02.008
52. Nassour M, Idoux-Gillet Y, Selmi A, Come C, Faraldo ML, Deugnier MA, Savagner P. Slug controls stem/progenitor cell growth dynamics during mammary gland morphogenesis. PLoS One 2012; 7: e53498; PMID: 23300933; http://dx.doi.org/10.1371/journal.pone.0053498
53. Stingl J, Eirew P, Ricketson I, Shackleton M, Vaillant F, Choi D, Li HI, Eaves CJ. Purification and unique properties of mammary epithelial stem cells. Nature 2006; 439: 993-7; PMID: 16395311; http://dx.doi.org/10.1038/nature04496
54. Al-Hajj M, Wicha MS, Benito-Hernandez A, Morrison SJ, Clarke MF. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003; 100: 3983-8; PMID: 12629218; http://dx.doi.org/10.1073/pnas.0530291100
55. Mani SA, Guo W, Liao MJ, Eaton EN, Ayyanan A, Zhou AY, Brooks M, Reinhard F, Zhang CC, Shipitsin M, et al. The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell 2008; 133: 704-15; PMID: 18485877; http://dx.doi.org/10.1016/j.cell.2008.03.027
56. Bhat-Nakshatri P, Appaiah H, Ballas C, Pick-Franke P, Goulet R, Jr, Badve S, Srour EF, Nakshatri H. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44C/CD24-phenotype. BMC Cancer 2010; 10: 411,2407-10-411; PMID: 20691079; http://dx.doi.org/10.1186/1471-2407-10-411
57. Morel AP, Lievre M, Thomas C, Hinkal G, Ansieau S, Puisieux A. Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One 2008; 3: e2888; PMID: 18682804; http://dx.doi.org/10.1371/journal.pone.0002888
58. van Amerongen R, Bowman AN, Nusse R. Developmental stage and time dictate the fate of wnt/beta-catenin-responsive stem cells in the mammary gland. Cell Stem Cell 2012; 11: 387-400; PMID: 22863533; http://dx.doi.org/10.1016/j.stem.2012.05.023
59. Holm K, Hegardt C, Staaf J, Vallon-Christersson J, Jonsson G, Olsson H, Borg A, Ringner M. Molecular subtypes of breast cancer are associated with characteristic DNA methylation patterns. Breast Cancer Res 2010; 12: R36; PMID: 20565864; http://dx.doi.org/10.1186/bcr2590 [doi]
60. Kagara N, Huynh KT, Kuo C, Okano H, Sim MS, Elashoff D, Chong K, Giuliano AE, Hoon DS. Epigenetic regulation of cancer stem cell genes in triple-negative breast cancer. Am J Pathol 2012; 181: 257-67; PMID: 22626806; http://dx.doi.org/10.1016/j.ajpath.2012.03.019 [doi]
61. Chang CJ, Yang JY, Xia W, Chen CT, Xie X, Chao CH, Woodward WA, Hsu JM, Hortobagyi GN, Hung MC. EZH2 promotes expansion of breast tumor initiating cells through activation of RAF1-beta-catenin signaling. Cancer Cell 2011; 19: 86-100; PMID: 21215703; http://dx.doi.org/10.1016/j.ccr.2010.10.035 [doi]
62. Yamamoto M, Ito T, Shimizu T, Ishida T, Semba K, Watanabe S, Yamaguchi N, Inoue J. Epigenetic alteration of the NF-kappaB-inducing kinase (NIK) gene is involved in enhanced NIK expression in basal-like breast cancer. Cancer Sci 2010; 101: 2391-7; PMID: 20735436; http://dx.doi.org/10.1111/j.1349-7006.2010.01685.x [doi]
63. Byler S, Goldgar S, Heerboth S, Leary M, Housman G, Moulton K, Sarkar S. Genetic and epigenetic aspects of breast cancer progression and therapy. Anticancer Res 2014; 34: 1071-7; PMID: 24596345; http://dx.doi.org/34/3/1071 [pii]
64. Schwitalla S, Fingerle AA, Cammareri P, Nebelsiek T, Goktuna SI, Ziegler PK, Canli O, Heijmans J, Huels DJ, Moreaux G, et al. Intestinal tumorigenesis initiated by dedifferentiation and acquisition of stem-celllike properties. Cell 2013; 152: 25-38; PMID: 23273993; http://dx.doi.org/10.1016/j.cell.2012.12.012
65. Youssef KK, Lapouge G, Bouvree K, Rorive S, Brohee S, Appelstein O, Larsimont JC, Sukumaran V, Van de Sande B, Pucci D, et al. Adult interfollicular tumour-initiating cells are reprogrammed into an embryonic hair follicle progenitor-like fate during basal cell carcinoma initiation. Nat Cell Biol 2012; 14: 1282-94; PMID: 23178882; http://dx.doi.org/10.1038/ncb2628
66. Batlle E, Sancho E, Franci C, Dominguez D, Monfar M, Baulida J, Garcia De Herreros A. The transcription factor snail is a repressor of E-cadherin gene expression in epithelial tumour cells. Nat Cell Biol 2000; 2: 84-9; PMID: 10655587; http://dx.doi.org/10.1038/35000034
67. Sarrio D, Rodriguez-Pinilla SM, Hardisson D, Cano A, Moreno-Bueno G, Palacios J. Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. Cancer Res 2008; 68: 989-97; PMID: 18281472; http://dx.doi.org/10.1158/0008-5472.CAN-07-2017 [doi]
68. de Herreros AG, Peiro S, Nassour M, Savagner P. Snail family regulation and epithelial mesenchymal transitions in breast cancer progression. J Mammary Gland Biol Neoplasia 2010; 15: 135-47; PMID: 20455012; http://dx.doi.org/10.1007/s10911-010-9179-8
69. Liu T, Zhang X, Shang M, Zhang Y, Xia B, Niu M, Liu Y, Pang D. Dysregulated expression of slug, vimentin, and E-cadherin correlates with poor clinical outcome in patients with basal-like breast cancer. J Surg Oncol 2013; 107: 188-94; PMID: 22886823; http://dx.doi.org/10.1002/jso.23240
70. Alves CC, Carneiro F, Hoefler H, Becker KF. Role of the epithelial-mesenchymal transition regulator slug in primary human cancers. Front Biosci (Landmark Ed) 2009; 14: 3035-50; PMID: 19273255
71. Shook D, Keller R. Mechanisms, mechanics and function of epithelial-mesenchymal transitions in early development. Mech Dev 2003; 120: 1351-83; PMID: 14623443
72. Storci G, Sansone P, Trere D, Tavolari S, Taffurelli M, Ceccarelli C, Guarnieri T, Paterini P, Pariali M, Montanaro L, et al. The basal-like breast carcinoma phenotype is regulated by SLUG gene expression. J Pathol 2008; 214: 25-37; PMID: 17973239; http://dx.doi.org/10.1002/path.2254
73. Hajra KM, Chen DY, Fearon ER. The SLUG zincfinger protein represses E-cadherin in breast cancer. Cancer Res 2002; 62: 1613-8; PMID: 11912130
74. Martin TA, Goyal A, Watkins G, Jiang WG. Expression of the transcription factors snail, slug, and twist and their clinical significance in human breast cancer. Ann Surg Oncol 2005; 12: 488-96; PMID: 15864483; http://dx.doi.org/10.1245/ASO.2005.04.010
75. Choi Y, Lee HJ, Jang MH, Gwak JM, Lee KS, Kim EJ, Kim HJ, Lee HE, Park SY. Epithelial-mesenchymal transition increases during the progression of in situ to invasive basal-like breast cancer. Hum Pathol 2013; 44: 2581-9; PMID: 24055090; http://dx.doi.org/10.1016/j.humpath.2013.07.003 [doi]
76. Leroy P, Mostov KE. Slug is required for cell survival during partial epithelial-mesenchymal transition of HGF-induced tubulogenesis. Mol Biol Cell 2007; 18: 1943-52; PMID: 17344479; http://dx.doi.org/10.1091/mbc.E06-09-0823
77. Ewald AJ, Huebner RJ, Palsdottir H, Lee JK, Perez MJ, Jorgens DM, Tauscher AN, Cheung KJ, Werb Z, Auer M. Mammary collective cell migration involves transient loss of epithelial features and individual cell migration within the epithelium. J Cell Sci 2012; 125: 2638-54; PMID: 22344263; http://dx.doi.org/10.1242/jcs.096875
78. Sorlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR, Borresen-Dale AL. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: Gene expression analyses across three different platforms. BMC Genomics 2006; 7: 127; PMID: 16729877; http://dx.doi.org/1471-2164-7-127 [pii]
79. Rouzier R, Perou CM, Symmans WF, Ibrahim N, Cristofanilli M, Anderson K, Hess KR, Stec J, Ayers M, Wagner P, et al. Breast cancer molecular subtypes respond differently to preoperative chemotherapy. Clin Cancer Res 2005; 11: 5678-85; PMID: 16115903; http://dx.doi.org/11/16/5678 [pii]
80. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA, Pollack JR, Ross DT, Johnsen H, Akslen LA, et al. Molecular portraits of human breast tumours. Nature 2000; 406: 747-52; PMID: 10963602; http://dx.doi.org/10.1038/35021093
81. Rakha EA, Ellis IO. Triple-negative/basal-like breast cancer: Review. Pathology 2009; 41: 40-7; PMID: 19089739; http://dx.doi.org/10.1080/00313020802563510
82. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H, Hastie T, Eisen MB, van de Rijn M, Jeffrey SS, et al. Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci U S A 2001; 98: 10869-74; PMID: 11553815; http://dx.doi.org/10.1073/pnas.191367098
83. Bertucci F, Finetti P, Birnbaum D. Basal breast cancer: A complex and deadly molecular subtype. Curr Mol Med 2012; 12: 96-110; PMID: 22082486; http://dx.doi.org/BSP/CMM/E-Pub/00017 [pii]
84. Ishihara A, Tsuda H, Kitagawa K, Yoneda M, Shiraishi T. Morphological characteristics of basal-like subtype of breast carcinoma with special reference to cytopathological features. Breast Cancer 2009; 16: 179-85; PMID: 19466513; http://dx.doi.org/10.1007/s12282-009-0108-x [doi]
85. Arnes JB, Brunet JS, Stefansson I, Begin LR, Wong N, Chappuis PO, Akslen LA, Foulkes WD. Placental cadherin and the basal epithelial phenotype of BRCA1-related breast cancer. Clin Cancer Res 2005; 11: 4003-11; PMID: 15930334; http://dx.doi.org/11/11/4003 [pii]
86. Foulkes WD, Brunet JS, Stefansson IM, Straume O, Chappuis PO, Begin LR, Hamel N, Goffin JR, Wong N, Trudel M, et al. The prognostic implication of the basal-like (cyclin E high/p27 low/p53C/glomeruloidmicrovascular-proliferationC) phenotype of BRCA1-related breast cancer. Cancer Res 2004; 64: 830-5; PMID: 14871808
87. Livasy CA, Karaca G, Nanda R, Tretiakova MS, Olopade OI, Moore DT, Perou CM. Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma. Mod Pathol 2006; 19: 264-71; PMID: 16341146; http://dx.doi.org/3800528 [pii]
88. Gusterson B. Do 'basal-like' breast cancers really exist? Nat Rev Cancer 2009; 9: 128-34; PMID: 19132008; http://dx.doi.org/10.1038/nrc2571;10.1038/nrc2571
89. Bertucci F, Cervera N, Birnbaum D. A gene signature in breast cancer. N Engl J Med 2007; 356: 1887,8; author reply 1887-8; PMID: 17476019; http://dx.doi.org/356/18/1887 [pii]
90. Charafe-Jauffret E, Ginestier C, Monville F, Finetti P, Adelaide J, Cervera N, Fekairi S, Xerri L, Jacquemier J, Birnbaum D, et al. Gene expression profiling of breast cell lines identifies potential new basal markers. Oncogene 2006; 25: 2273-84; PMID: 16288205; http://dx.doi.org/1209254 [pii]
91. Liu R, Wang X, Chen GY, Dalerba P, Gurney A, Hoey T, Sherlock G, Lewicki J, Shedden K, Clarke MF. The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 2007; 356: 217-26; PMID: 17229949; http://dx.doi.org/356/3/217 [pii]
92. Zvelebil M, Oliemuller E, Gao Q, Wansbury O, Mackay A, Kendrick H, Smalley MJ, Reis-Filho JS, Howard BA. Embryonic mammary signature subsets are activated in Brca1-/-and basal-like breast cancers. Breast Cancer Res 2013; 15: R25; PMID: 23506684; http://dx.doi.org/10.1186/bcr3403
93. Fillmore CM, Kuperwasser C. Human breast cancer cell lines contain stem-like cells that self-renew, give rise to phenotypically diverse progeny and survive chemotherapy. Breast Cancer Res 2008; 10: R25; PMID: 18366788; http://dx.doi.org/10.1186/bcr1982 [doi]
94. Sheridan C, KishimotoH, Fuchs RK, Mehrotra S, Bhat-Nakshatri P, Turner CH, Goulet R, Jr, Badve S, Nakshatri H. CD44C/CD24-breast cancer cells exhibit enhanced invasive properties: An early step necessary for metastasis. Breast Cancer Res 2006; 8: R59; PMID: 17062128; http://dx.doi.org/bcr1610 [pii]
95. Park SY, Lee HE, Li H, Shipitsin M, Gelman R, Polyak K. Heterogeneity for stem cell-related markers according to tumor subtype and histologic stage in breast cancer. Clin Cancer Res 2010; 16: 876-87; PMID: 20103682; http://dx.doi.org/10.1158/1078-0432.CCR-09-1532 [doi]
96. Honeth G, Bendahl PO, Ringner M, Saal LH, Gruvberger-Saal SK, Lovgren K, Grabau D, Ferno M, Borg A, Hegardt C. The CD44C/CD24-phenotype is enriched in basal-like breast tumors. Breast Cancer Res 2008; 10: R53; PMID: 18559090; http://dx.doi.org/10.1186/bcr2108
97. Keller PJ, Arendt LM, Kuperwasser C. Stem cell maintenance of the mammary gland: It takes two. Cell Stem Cell 2011; 9: 496-7; PMID: 22136921; http://dx.doi.org/10.1016/j.stem.2011.11.008
98. Keller PJ, Arendt LM, Skibinski A, Logvinenko T, Klebba I, Dong S, Smith AE, Prat A, Perou CM, Gilmore H, et al. Defining the cellular precursors to human breast cancer. Proc Natl Acad Sci U S A 2012; 109: 2772-7; PMID: 21940501; http://dx.doi.org/10.1073/pnas.1017626108
99. Molyneux G, Geyer FC, Magnay FA, McCarthy A, Kendrick H, Natrajan R, Mackay A, Grigoriadis A, Tutt A, Ashworth A, et al. BRCA1 basal-like breast cancers originate from luminal epithelial progenitors and not from basal stem cells. Cell Stem Cell 2010; 7: 403-17; PMID: 20804975; http://dx.doi.org/10.1016/j.stem.2010.07.010
100. Furuta S, Jiang X, Gu B, Cheng E, Chen PL, Lee WH. Depletion of BRCA1 impairs differentiation but enhances proliferation of mammary epithelial cells. Proc Natl Acad Sci U S A 2005; 102: 9176-81; PMID: 15967981; http://dx.doi.org/0503793102 [pii]
101. Kubista M, Rosner M, Kubista E, Bernaschek G, Hengstschlager M. Brca1 regulates in vitro differentiation of mammary epithelial cells. Oncogene 2002; 21: 4747-56; PMID: 12101413; http://dx.doi.org/10.1038/sj.onc.1205580 [doi]
102. Liu S, Ginestier C, Charafe-Jauffret E, Foco H, Kleer CG, Merajver SD, Dontu G, Wicha MS. BRCA1 regulates human mammary stem/progenitor cell fate. Proc Natl Acad Sci U S A 2008; 105: 1680-5; PMID: 18230721; http://dx.doi.org/10.1073/pnas.0711613105 [doi]
103. Cloos PA, Christensen J, Agger K, Helin K. Erasing the methyl mark: Histone demethylases at the center of cellular differentiation and disease. Genes Dev 2008; 22: 1115-40; PMID: 18451103; http://dx.doi.org/10.1101/gad.1652908
104. Peinado H, Ballestar E, Esteller M, Cano A. Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol 2004; 24: 306-19; PMID: 14673164
105. Hou Z, Peng H, Ayyanathan K, Yan KP, Langer EM, Longmore GD, Rauscher FJ, 3rd. The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression. Mol Cell Biol 2008; 28: 3198-207; PMID: 18347060; http://dx.doi.org/10.1128/MCB.01435-07
106. Dong C, Wu Y, Wang Y, Wang C, Kang T, Rychahou PG, Chi YI, Evers BM, Zhou BP. Interaction with Suv39H1 is critical for snail-mediated E-cadherin repression in breast cancer. Oncogene 2013; 32: 1351-62; PMID: 22562246; http://dx.doi.org/10.1038/onc.2012.169 [doi]
107. Dong C, Wu Y, Yao J, Wang Y, Yu Y, Rychahou PG, Evers BM, Zhou BP. G9a interacts with snail and is critical for snail-mediated E-cadherin repression in human breast cancer. J Clin Invest 2012; 122: 1469-86; PMID: 22406531; http://dx.doi.org/10.1172/JCI57349 [doi]
108. Herranz N, Pasini D, Diaz VM, Franci C, Gutierrez A, Dave N, Escriva M, Hernandez-Munoz I, Di Croce L, Helin K, et al. Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor. Mol Cell Biol 2008; 28: 4772-81; PMID: 18519590; http://dx.doi.org/10.1128/MCB.00323-08
109. Lin T, Ponn A, Hu X, Law BK, Lu J. Requirement of the histone demethylase LSD1 in Snai1-mediated transcriptional repression during epithelial-mesenchymal transition. Oncogene 2010; 29: 4896-904; PMID: 20562920; http://dx.doi.org/10.1038/onc.2010.234
110. Shi YJ, Matson C, Lan F, Iwase S, Baba T, Shi Y. Regulation of LSD1 histone demethylase activity by its associated factors. Mol Cell 2005; 19: 857-64; PMID: 16140033; http://dx.doi.org/10.1016/j.molcel.2005.08.027
111. Saleque S, Kim J, Rooke HM, Orkin SH. Epigenetic regulation of hematopoietic differentiation by gfi-1 and gfi-1b is mediated by the cofactors CoREST and LSD1. Mol Cell 2007; 27: 562-72; PMID: 17707228; http://dx.doi.org/10.1016/j.molcel.2007.06.039
112. Lin Y, Wu Y, Li J, Dong C, Ye X, Chi YI, Evers BM, Zhou BP. The SNAG domain of Snail1 functions as a molecular hook for recruiting lysine-specific demethylase 1. EMBO J 2010; 29: 1803-16; PMID: 20389281; http://dx.doi.org/10.1038/emboj.2010.63 [doi]
113. Wu ZQ, Li XY, Hu CY, Ford M, Kleer CG, Weiss SJ. Canonical wnt signaling regulates slug activity and links epithelial-mesenchymal transition with epigenetic breast cancer 1, early onset (BRCA1) repression. Proc Natl Acad Sci U S A 2012; 109: 16654-9; PMID: 23011797; http://dx.doi.org/10.1073/pnas.1205822109
114. Lim S, Janzer A, Becker A, Zimmer A, Schule R, Buettner R, Kirfel J. Lysine-specific demethylase 1 (LSD1) is highly expressed in ER-negative breast cancers and a biomarker predicting aggressive biology. Carcinogenesis 2010; 31: 512-20; PMID: 20042638; http://dx.doi.org/10.1093/carcin/bgp324.